alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 4.1    
    


SEE RESTRICTIVE LEGEND ON THE REVERSE SIDE OF THIS CERTIFICATE  


Incorporated
Under The Laws Of The

State Of Maryland 



	Number	 	Shares
	

 	
 	

 
	
	 	







	
INFOSONICS CORPORATION
	

$.001 Par Value Common Stock, 40,000,000 Shares Authorized
	 





THIS CERTIFIES THAT                                         
       
 is the registered holder of



	

shares of the $.001 par value Common Stock of





InfoSonics Corporation, fully paid and non-assessable,

transferable only on the books of the Corporation by the holder hereof in person or by Attorney upon

surrender of this Certificate properly endorsed.
  IN WITNESS WHEREOF, the said Corporation has caused this

Section 1. Certificate to be signed by its duly authorized officers and its Corporate

Seal to be hereunto affixed as of this            day of            , A.D. 20    .  



	

 	
 	

 
	
	 	

	Abraham Rosler, Secretary	 	Joseph Ram, President
	 	 	 












QuickLinks



Exhibit 4.1
I 

113TH CONGRESS 

1ST SESSION H. R. 1037 

To amend the Public Health Service Act to include occupational therapists 

as behavioral and mental health professionals for purposes of the National Health Service Corps. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 7, 2013 

Mr. TONKO (for himself, Ms. BROWN of Florida, and Ms. SLAUGHTER) introduced the following bill; which was referred to the Committee on Energy 

and Commerce 

A BILL 

To amend the Public Health Service Act to include occupational therapists as behavioral and mental health professionals for purposes of the National Health Service 

Corps. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Occupational Therapy 

5 in Mental Health Act’’. 


smartinez on DSK6TPTVN1PROD with BILLS
2 

•HR 1037 IH

1 SEC. 2. INCLUDING OCCUPATIONAL THERAPISTS AS BE2 HAVIORAL AND MENTAL HEALTH PROFES3 SIONALS FOR PURPOSES OF THE NATIONAL 

4 HEALTH SERVICE CORPS. 

5 Section 331(a)(1)(E)(i) of the Public Health Service 

6 Act (42 U.S.C. 254d(a)(1)(E)(i)) is amended by inserting 

7 ‘‘occupational therapists,’’ after ‘‘psychiatric nurse spe8 cialists,’’. 

Æ 


smartinez on DSK6TPTVN1PROD with BILLS
I 

113TH CONGRESS 

1ST SESSION H. R. 1055 

To suspend temporarily the duty on Disperse Violet 57. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 11, 2013 

Mr. WATT introduced the following bill; which was referred to the Committee 

on Ways and Means 

A BILL 

To suspend temporarily the duty on Disperse Violet 57. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. DISPERSE VIOLET 57. 

4 (a) IN GENERAL.—Subchapter II of chapter 99 of 

5 the Harmonized Tariff Schedule of the United States is 

6 amended by inserting in numerical sequence the following 

7 new heading: 

‘‘ 9902.01.00 Disperse Violet 57 (CAS 

No. 1594–08–7) (provided 

for in subheading 

3204.11.10) ....................... Free No change No change On or before 

12/31/2016 ’’. 

8 (b) EFFECTIVE DATE.—The amendment made by 

9 subsection (a) applies to articles entered, or withdrawn 


jbell on DSK7SPTVN1PROD with BILLS
2 

•HR 1055 IH

1 from warehouse for consumption, on or after the 15th day 

2 after the date of the enactment of this Act. 

Æ 


jbell on DSK7SPTVN1PROD with BILLS
CONSENT OF INDEPENDENT AUDITORS

The Board of Directors
Wave Systems Corp.

We consent to the incorporation by reference in the registration statements Nos.
333-38265, 333-28819, and 333-20017 on Form S-3 and Nos. 33-97612, 333-11611 and
333-11609  on Form S-8,  of our report  dated  March 27,  1998,  relating to the
consolidated  balance  sheets  of Wave  Systems  Corp.  and  subsidiaries  as of
December  31,  1997  and  1996,  and  the  related  consolidated  statements  of
operations,  stockholders' equity  (deficiency),  and cash flows for each of the
years in the three-year ended December 31, 1997 and for the period from February
12, 1998  (inception)  through  December  31, 1997 which  report  appears in the
December 31, 1997 annual report on Form 10-K of Wave Systems Corp.

Our report dated March 27, 1998 contains an  explanatory  paragraph  that states
that the Company has suffered  recurring  losses from operations since inception
that raise  substantial  doubt about its ability to continue as a going concern.
The consolidated  financial statements do not include any adjustments that might
result from the outcome of that uncertainty.

                                                       KPMG Peat Marwick LLP

Boston, Massachusetts
March 31, 1998
III 

113TH CONGRESS 

2D SESSION H. CON. RES. 88 

IN THE SENATE OF THE UNITED STATES 

APRIL 2, 2014 

Received 

CONCURRENT RESOLUTION 

Authorizing the use of the Capitol Grounds for the Greater 

Washington Soap Box Derby. 

1 Resolved by the House of Representatives (the Senate 

2 concurring), 

3 SECTION 1. USE OF CAPITOL GROUNDS FOR SOAP BOX 

4 DERBY RACES. 

5 (a) IN GENERAL.—The Greater Washington Soap 

6 Box Derby Association (in this resolution referred to as 

7 the ‘‘sponsor’’) shall be permitted to sponsor a public 


sroberts on DSK5SPTVN1PROD with BILLS
2 

HCON 88 RDS 

1 event, soap box derby races (in this resolution referred to 

2 as the ‘‘event’’), on the Capitol Grounds. 

3 (b) DATE OF EVENT.—The event shall be held on 

4 June 14, 2014, or on such other date as the Speaker of 

5 the House of Representatives and the Committee on Rules 

6 and Administration of the Senate jointly designate. 

7 SEC. 2. TERMS AND CONDITIONS. 

8 (a) IN GENERAL.—Under conditions to be prescribed 

9 by the Architect of the Capitol and the Capitol Police 

10 Board, the event shall be— 

11 (1) free of admission charge and open to the 

12 public; and 

13 (2) arranged not to interfere with the needs of 

14 Congress. 

15 (b) EXPENSES AND LIABILITIES.—The sponsor shall 

16 assume full responsibility for all expenses and liabilities 

17 incident to all activities associated with the event. 

18 SEC. 3. EVENT PREPARATIONS. 

19 Subject to the approval of the Architect of the Cap20 itol, the sponsor is authorized to erect upon the Capitol 

21 Grounds such stage, sound amplification devices, and 

22 other related structures and equipment as may be required 

23 for the event. 


sroberts on DSK5SPTVN1PROD with BILLS
3 

HCON 88 RDS 

1 SEC. 4. ADDITIONAL ARRANGEMENTS. 

2 The Architect of the Capitol and the Capitol Police 

3 Board are authorized to make such additional arrange4 ments as may be required to carry out the event. 

5 SEC. 5. ENFORCEMENT OF RESTRICTIONS. 

6 The Capitol Police Board shall provide for enforce7 ment of the restrictions contained in section 5104(c) of 

8 title 40, United States Code, concerning sales, advertise9 ments, displays, and solicitations on the Capitol Grounds, 

10 as well as other restrictions applicable to the Capitol 

11 Grounds, with respect to the event. 

Passed the House of Representatives April 1, 2014. 

Attest: KAREN L. HAAS, 

Clerk. 


sroberts on DSK5SPTVN1PROD with BILLS
```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[H.J. Res. 131 Engrossed in House (EH)]

113th CONGRESS
  2d Session
H. J. RES. 131

_______________________________________________________________________

                            JOINT RESOLUTION

 
Making further continuing appropriations for fiscal year 2015, and for 
                            other purposes.

    Resolved by the Senate and House of Representatives of the United 
States of America in Congress assembled, That the Continuing 
Appropriations Resolution, 2015 (Public Law 113-164) is further amended 
by striking the

              

 date specified in section 106(3) and inserting ``December 17, 2014''.

            Passed the House of Representatives December 12, 2014.

            Attest:

                                                                 Clerk.
113th CONGRESS

  2d Session

                             H. J. RES. 131

_______________________________________________________________________

                            JOINT RESOLUTION

Making further continuing appropriations for fiscal year 2015, and for 
                            other purposes.
```
Filed by Automated Filing Services Inc. (604) 609-0244 - Response Biomedical Corp. - Exhibit 10.1





CONSENT OF INDEPENDENT CHARTERED ACCOUNTANTS

 

We consent to the use of our report dated February 25, 2003
  and our Comments by Auditors for United States Readers on Canada-United States
  Reporting Difference (which includes an explanatory paragraph describing conditions
  that raise substantial doubt about the Company’s ability to continue as
  a going concern as described in Note 1 to the consolidated financial statements)
  dated February 25, 2003, with respect to the consolidated financial statements
  of Response Biomedical Corp. as at December 31, 2002 and 2001 and for each of
  the years in the three year period ended December 31, 2002 included in the Registration
  Statement (Form 20-F), dated January 30, 2004.

	Vancouver, Canada, 	/s/ Ernst & Young LLP
	January 30, 2004.	Chartered Accountants
Amendment Number One



 Exhibit 10.38(ix) 
  
 AMENDMENT NUMBER ONE TO THE 
 JAMES RIVER CORPORATION OF VIRGINIA 1987 STOCK OPTION PLAN 
 (As Amended and Restated Effective
December 16, 1993) 
  
 WHEREAS, Georgia-Pacific Corporation
(the “Company”) assumed the James River Corporation of Virginia 1987 Stock Option Plan as amended and restated as of December 16, 1993 (the “Plan”) in connection with its acquisition of Fort James Corporation in November 2000;
and 
  
 WHEREAS, pursuant to Section 11 of the Plan, the Board of
Directors of the Company has the right to amend the Plan, with the approval of the shareholders of the Company where necessary or advisable; and 
  
 WHEREAS, at its January 31, 2003 meeting, the Board of Directors of the Company delegated to its Compensation Committee (the “G-P Committee”)
the authority to approve amendments to the Plan as necessary or appropriate to effectuate a program to offer employees an opportunity to exchange outstanding stock options under various option plans of the Company and its subsidiaries for a lesser
number of restricted shares to be granted under the Georgia-Pacific Corporation Long-Term Incentive Plan, for the purpose of motivating and retaining employees; 
  

NOW, THEREFORE, the G-P Committee hereby amends the Plan as follows, subject to and effective as of the date of shareholder approval: 
  
 1. The definition of “Company” in Section 2(g) of the Plan, is
amended to read as follows: 
  
 “COMPANY” from and
after the acquisition of Fort James Corporation by Georgia-Pacific Corporation in November 2000, means Georgia-Pacific Corporation, which assumed the Plan in connection with such acquisition. 
  
 2. A new Section 13A is added immediately following Section 13, to read as
follows: 
  
 “13A. OPTIONS PREVIOUSLY GRANTED. 

 
 Unless approved in advance by the shareholders of the
Company, the term of an outstanding Option may not be extended, and the exercise price of an outstanding Option may not be reduced, directly or indirectly, whether through direct amendment to the exercise price, through cancellation and replacement
of the Option, or otherwise. Notwithstanding the foregoing, the Company may effect a one-time exchange offer to be commenced in the discretion of the Company no sooner than May 6, 2003 and no later than the 2004 annual meeting of the Company’s
shareholders, upon the terms and conditions described in the proxy statement for the 2003 annual meeting of the shareholders of the Company and in a Schedule TO to be filed with the Securities and Exchange Commission on or about May 6, 2003, as the
same may be amended (the “2003 Exchange Offer”). Upon surrender of Options granted under the Plan pursuant to the 2003 Exchange Offer, the underlying shares shall not be available for future grants under the Plan.”
[Federal Register Volume 87, Number 110 (Wednesday, June 8, 2022)]
[Notices]
[Page 34892]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-12338]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Heart, Lung, and Blood Initial Review Group; 
NHLBI Single-Site and Pilot Clinical Trials Study Section.
    Date: June 22-23, 2022.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: YingYing Li-Smerin, MD, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, 6705 Rockledge Drive, Room 207-P, Bethesda, MD 
20892-7924, 301-827-7942, <a href="/cdn-cgi/l/email-protection#c2aeabb1afa7b0abac82acaaaea0abecacabaaeca5adb4"><span class="__cf_email__" data-cfemail="e78b8e948a82958e89a7898f8b858ec9898e8fc9808891">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: June 3, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-12338 Filed 6-7-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<PAGE>
                                                                    Exhibit 4.12

                              CERTIFICATE OF TRUST

                                       OF

                            GOLDMAN SACHS CAPITAL II

      This Certificate of Trust of Goldman Sachs Capital II (the "Trust"), dated
as of January 20, 2004, is being duly executed and filed by the undersigned, as
trustees, to form a statutory trust under the Delaware Statutory Trust Act (12
Del. C. Section 3801, et seq.)(the "Act").

      1. Name. The name of the statutory trust being formed hereby is Goldman
Sachs Capital II.

      2. Delaware Trustee. The name and business address of the trustee of the
Trust, with a principal place of business in the State of Delaware, are The Bank
of New York (Delaware), White Clay Center, Route 273, Newark, Delaware 19711.

      3. Effective Date. This Certificate of Trust shall be effective as of its
filing with the Secretary of State of the State of Delaware.

      IN WITNESS WHEREOF, the undersigned has duly executed this Certificate of
Trust in accordance with Section 3811(a)(1) of the Act as of the date first
above written.

                                   THE BANK OF NEW YORK (DELAWARE), not in its
                                   individual capacity, but solely as trustee


                                   By: /s/ William T. Lewis
                                       ______________________________
                                       Name:  William T. Lewis
                                       Title: Sr. Vice President
Clarence Wayne DIXON, Petitioner, v. David SHINN, Director, Arizona Department of Corrections, et al.

No. 19-8022.

Supreme Court of the United States.

May 26, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
Ernest COLLINS, Petitioner, v. BARNES & THORNBURG LLP, et al.

No. 19-6982.

Supreme Court of the United States.

May 4, 2020

Petition for rehearing denied.
IN RE Lexter K. KOSSIE, Petitioner.

No. 18-9656.

Supreme Court of the United States.

Oct. 7, 2019.

Petition for writ of habeas corpus denied.
Exhibit 31.1

 

**CERTIFICATIONS**

 

I, Clive Barwin, certify that:
| 1. | I have reviewed this quarterly report on Form 10-QSB of Melt Inc.; |
|----|--------------------------------------------------------------------|

2.            Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3.            Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this quarterly report;

4.             I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and I have:

a)             designed such disclosure controls and procedures to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b)            evaluated the effectiveness of the small business issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this quarterly report based on such evaluation; and

c)             disclosed in this quarterly report any change in the small business issuer’s internal control over financial reporting that occurred during the small business issuer’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the small business issuer’s internal control over financial reporting.

5.             I have disclosed, based on my most recent evaluation of internal controls over financial reporting, to the small business issuer’s auditors and the audit committee of the small business issuer’s board of directors (or persons performing the equivalent functions):

a)             all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer’s ability to record, process, summarize and report financial information; and

b)            any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer’s internal control over financial reporting.

 

Date: November 14, 2006

 

/s/ Clive Barwin                                                                            

Clive Barwin, President, CEO and Secretary 

(Principal Executive Officer and Principal Financial Officer)
EXHIBIT 32.a



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of BCTC V Assignor Corp. (the "registrant") on Form 10-Q for the period ended June 30, 2007 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, John P. Manning, Principal Executive Officer of registrant, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge, after due inquiry:



|(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and                                  
|--- | -------------------------------------------------------------------------------------------------------------------------------------------------------
|    |                                                                                                                                                        
|(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the registrant.



|                |  |                            
|--------------- |  | ---------------------------
|Date:           |  |                            
|August 14, 2007 |  | /s/ John P. Manning        
|                |  |                            
|                |  | John P. Manning            
|                |  | Principal Executive Officer
|                |  |                            
|                |  |                            



A signed original of this written statement required by Section 906, or other

document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the registrant and will be retained by the registrant and furnished to the Securities and Exchange Commission or its staff upon request.
# C_2018459EN.01000102.xml

| 20.12.2018 | EN | Official Journal of the European Union | C 459/1 |
| --- | --- | --- | --- |

20.12.2018

EN

Official Journal of the European Union

C 459/1

---

Non-opposition to a notified concentration

(Case M.9166 — Santander Group/Hyundai Motor Company Group/JV)

(Text with EEA relevance)

(2018/C 459/02)

On 7 December 2018, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M9166. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M9166. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---